JP3997436B2 - 電気化学発光技術による化合物のモニターリング - Google Patents
電気化学発光技術による化合物のモニターリング Download PDFInfo
- Publication number
- JP3997436B2 JP3997436B2 JP50202097A JP50202097A JP3997436B2 JP 3997436 B2 JP3997436 B2 JP 3997436B2 JP 50202097 A JP50202097 A JP 50202097A JP 50202097 A JP50202097 A JP 50202097A JP 3997436 B2 JP3997436 B2 JP 3997436B2
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- label
- ecl
- ctfc
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 115
- 238000012544 monitoring process Methods 0.000 title claims abstract description 19
- 238000005516 engineering process Methods 0.000 title description 5
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000006243 chemical reaction Methods 0.000 claims description 59
- 238000004020 luminiscence type Methods 0.000 claims description 42
- 229950006238 nadide Drugs 0.000 claims description 33
- 102000004190 Enzymes Human genes 0.000 claims description 32
- 108090000790 Enzymes Proteins 0.000 claims description 32
- 239000000758 substrate Substances 0.000 claims description 29
- 150000003952 β-lactams Chemical class 0.000 claims description 27
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 claims description 25
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 claims description 25
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims description 24
- 229960000723 ampicillin Drugs 0.000 claims description 24
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 24
- 239000000126 substance Substances 0.000 claims description 19
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 16
- 239000012488 sample solution Substances 0.000 claims description 14
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 claims description 13
- 102000006635 beta-lactamase Human genes 0.000 claims description 11
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 10
- 230000003993 interaction Effects 0.000 claims description 10
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 10
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 8
- -1 cefotine Chemical compound 0.000 claims description 8
- 238000005259 measurement Methods 0.000 claims description 5
- 239000000523 sample Substances 0.000 claims description 5
- 239000012491 analyte Substances 0.000 claims description 4
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 17
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 4
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 claims 4
- 230000003197 catalytic effect Effects 0.000 claims 3
- JWCSIUVGFCSJCK-CAVRMKNVSA-N Disodium Moxalactam Chemical compound N([C@]1(OC)C(N2C(=C(CSC=3N(N=NN=3)C)CO[C@@H]21)C(O)=O)=O)C(=O)C(C(O)=O)C1=CC=C(O)C=C1 JWCSIUVGFCSJCK-CAVRMKNVSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims 2
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims 2
- 229960003022 amoxicillin Drugs 0.000 claims 2
- QYIYFLOTGYLRGG-GPCCPHFNSA-N cefaclor Chemical compound C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CS[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 QYIYFLOTGYLRGG-GPCCPHFNSA-N 0.000 claims 2
- 229960005361 cefaclor Drugs 0.000 claims 2
- 229960001668 cefuroxime Drugs 0.000 claims 2
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 claims 2
- 150000004696 coordination complex Chemical class 0.000 claims 2
- 229960000433 latamoxef Drugs 0.000 claims 2
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims 2
- 229940056360 penicillin g Drugs 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 1
- WZOZEZRFJCJXNZ-ZBFHGGJFSA-N cefoxitin Chemical compound N([C@]1(OC)C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)CC1=CC=CS1 WZOZEZRFJCJXNZ-ZBFHGGJFSA-N 0.000 claims 1
- 229960002682 cefoxitin Drugs 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 4
- 238000001378 electrochemiluminescence detection Methods 0.000 description 81
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 230000007062 hydrolysis Effects 0.000 description 34
- 238000006460 hydrolysis reaction Methods 0.000 description 34
- 239000003638 chemical reducing agent Substances 0.000 description 27
- 125000005647 linker group Chemical group 0.000 description 25
- 239000000243 solution Substances 0.000 description 25
- 230000007246 mechanism Effects 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 238000003556 assay Methods 0.000 description 17
- 230000000694 effects Effects 0.000 description 15
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 10
- 230000008901 benefit Effects 0.000 description 10
- 230000008859 change Effects 0.000 description 10
- 230000009467 reduction Effects 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- 241000894007 species Species 0.000 description 10
- 230000007071 enzymatic hydrolysis Effects 0.000 description 9
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000007254 oxidation reaction Methods 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 101710088194 Dehydrogenase Proteins 0.000 description 6
- 239000012327 Ruthenium complex Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 125000003460 beta-lactamyl group Chemical group 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000005424 photoluminescence Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 0 C*1=CC=C[C@]2OC2C1C1NCCCCC1 Chemical compound C*1=CC=C[C@]2OC2C1C1NCCCCC1 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000003446 ligand Substances 0.000 description 5
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 4
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 4
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910052707 ruthenium Inorganic materials 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 239000001488 sodium phosphate Substances 0.000 description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 4
- 241000193755 Bacillus cereus Species 0.000 description 3
- 108020005199 Dehydrogenases Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108010087702 Penicillinase Proteins 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000006056 electrooxidation reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- JEGMWWXJUXDNJN-UHFFFAOYSA-O CC1C[NH2+]CCC1 Chemical compound CC1C[NH2+]CCC1 JEGMWWXJUXDNJN-UHFFFAOYSA-O 0.000 description 1
- 241001660259 Cereus <cactus> Species 0.000 description 1
- DRSFVGQMPYTGJY-GNSLJVCWSA-N Deprodone propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)CC)[C@@]1(C)C[C@@H]2O DRSFVGQMPYTGJY-GNSLJVCWSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 1
- 102000002794 Glucosephosphate Dehydrogenase Human genes 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000011953 bioanalysis Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L magnesium chloride Substances [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- G01N2333/986—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides (3.5.2), e.g. beta-lactamase (penicillinase, 3.5.2.6), creatinine amidohydrolase (creatininase, EC 3.5.2.10), N-methylhydantoinase (3.5.2.6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2415/00—Assays, e.g. immunoassays or enzyme assays, involving penicillins or cephalosporins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/30—Electrochemically active labels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/40—Rare earth chelates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Electroluminescent Light Sources (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/485,419 | 1995-06-07 | ||
| US08/485,419 US5643713A (en) | 1995-06-07 | 1995-06-07 | Electrochemiluminescent monitoring of compounds |
| PCT/US1996/009805 WO1996040978A1 (en) | 1995-06-07 | 1996-06-07 | Electrochemiluminescent monitoring of compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006335216A Division JP2007176939A (ja) | 1995-06-07 | 2006-12-13 | 電気化学発光技術による化合物のモニターリング |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH11507533A JPH11507533A (ja) | 1999-07-06 |
| JPH11507533A5 JPH11507533A5 (enExample) | 2004-07-29 |
| JP3997436B2 true JP3997436B2 (ja) | 2007-10-24 |
Family
ID=23928088
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50202097A Expired - Fee Related JP3997436B2 (ja) | 1995-06-07 | 1996-06-07 | 電気化学発光技術による化合物のモニターリング |
| JP2006335216A Abandoned JP2007176939A (ja) | 1995-06-07 | 2006-12-13 | 電気化学発光技術による化合物のモニターリング |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006335216A Abandoned JP2007176939A (ja) | 1995-06-07 | 2006-12-13 | 電気化学発光技術による化合物のモニターリング |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US5643713A (enExample) |
| EP (1) | EP0836651B1 (enExample) |
| JP (2) | JP3997436B2 (enExample) |
| AT (1) | ATE317913T1 (enExample) |
| CA (1) | CA2222926C (enExample) |
| DE (1) | DE69635822T2 (enExample) |
| ES (1) | ES2258777T3 (enExample) |
| WO (1) | WO1996040978A1 (enExample) |
Families Citing this family (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010003647A1 (en) * | 1995-06-07 | 2001-06-14 | Ji Sun | Coreatant-including electrochemiluminescent compounds, methods, systems and kits utilizing same |
| US5641623A (en) * | 1995-01-04 | 1997-06-24 | Martin; Mark T. | Electrochemiluminescence assay |
| US6316180B1 (en) * | 1995-01-04 | 2001-11-13 | Igen International, Inc. | Electrochemiluminescent monitoring of compounds/electrochemiluminescence assays |
| US6319670B1 (en) | 1995-05-09 | 2001-11-20 | Meso Scale Technology Llp | Methods and apparatus for improved luminescence assays using microparticles |
| US6613583B1 (en) | 1997-06-27 | 2003-09-02 | Igen International, Inc. | Electrochemiluminescent label based on multimetallic assemblies |
| US6312896B1 (en) * | 1998-09-17 | 2001-11-06 | Igen Inaternational, Inc. | Assays for measuring nucleic acid binding proteins and enzyme activities |
| US7141436B2 (en) * | 1999-11-03 | 2006-11-28 | Science And Technology Corp. | Immunoassay and reagents and kits for performing the same |
| JP2004534226A (ja) | 2001-06-29 | 2004-11-11 | メソ スケイル テクノロジーズ，エルエルシー | 発光試験測定用のアッセイプレート、リーダシステム及び方法 |
| DK1412487T3 (da) | 2001-07-30 | 2010-08-30 | Meso Scale Technologies Llc | Assayelektroder der har immobiliserede lipid/proteinlag og fremgangsmåder til at fremstille og anvende disse |
| EP1451348B1 (en) | 2001-09-10 | 2015-08-12 | Meso Scale Technologies, LLC | Methods, reagents, kits and apparatus for protein function analysis |
| US20040197801A1 (en) * | 2002-11-15 | 2004-10-07 | Liu Timothy Z. | Nucleic acid sequence detection |
| US20080227219A1 (en) * | 2004-11-17 | 2008-09-18 | Frank Gamez | Electrochemiluminescent assay |
| US20060275841A1 (en) * | 2004-12-20 | 2006-12-07 | Martin Blankfard | Assay method and apparatus with reduced sample matrix effects |
| EP1854160B1 (en) * | 2005-02-10 | 2017-06-21 | Yeda Research And Development Co., Ltd. | Redox-active structures and devices utilizing the same |
| US20070116600A1 (en) * | 2005-06-23 | 2007-05-24 | Kochar Manish S | Detection device and methods associated therewith |
| EP2271938B1 (en) | 2008-04-11 | 2014-02-26 | Board of Regents of the University of Texas System | Method and apparatus for nanoparticle electrogenerated chemiluminescence amplification |
| EP2626692A3 (en) | 2008-05-08 | 2014-10-01 | Board of Regents of the University of Texas System | Luminescent nanostructured materials for use in electrogenerated chemiluminescence |
| US20100261292A1 (en) | 2009-04-10 | 2010-10-14 | Meso Scale Technologies, Llc | Methods for Conducting Assays |
| CN102753977B (zh) * | 2009-07-27 | 2016-05-25 | 梅索磅秤技术有限公司 | 化验装置、耗材和方法 |
| US20120157332A1 (en) | 2010-10-14 | 2012-06-21 | Meso Scale Technologies, Llc | Reagent Storage in an Assay Device |
| WO2012055815A1 (en) | 2010-10-25 | 2012-05-03 | Roche Diagnostics Gmbh | Use of signal enhancing compounds in electrochemiluminescence detection |
| ES2700792T3 (es) | 2011-11-11 | 2019-02-19 | Eli N Glezer | Procedimientos de ensayo asistidos por coagente de unión |
| US9081001B2 (en) | 2012-05-15 | 2015-07-14 | Wellstat Diagnostics, Llc | Diagnostic systems and instruments |
| US9213043B2 (en) | 2012-05-15 | 2015-12-15 | Wellstat Diagnostics, Llc | Clinical diagnostic system including instrument and cartridge |
| US9625465B2 (en) | 2012-05-15 | 2017-04-18 | Defined Diagnostics, Llc | Clinical diagnostic systems |
| US10281678B2 (en) | 2013-01-04 | 2019-05-07 | Meso Scale Technologies, Llc | Assay apparatuses, methods and reagants |
| EP4219750A3 (en) | 2013-03-11 | 2023-12-13 | Meso Scale Technologies, LLC. | Improved methods for conducting multiplexed assays |
| KR102257912B1 (ko) | 2013-03-13 | 2021-05-27 | 메소 스케일 테크놀러지즈, 엘엘시 | 개선된 분석 방법 |
| US10114015B2 (en) | 2013-03-13 | 2018-10-30 | Meso Scale Technologies, Llc. | Assay methods |
| MX347461B (es) | 2013-03-15 | 2017-04-26 | Lubrizol Advanced Mat Inc | Composiciones de cpvc libres de metales pesados. |
| IL229525A0 (en) | 2013-11-20 | 2014-01-30 | Yeda Res & Dev | Metal complexes of tris-bipyridyl and their uses in electrochromic applications |
| CA3229509A1 (en) | 2014-05-09 | 2015-11-12 | Meso Scale Technologies, Llc. | Graphene-modified electrodes |
| CN119709943A (zh) | 2014-05-15 | 2025-03-28 | 中尺度技术有限责任公司 | 改进的测定方法 |
| KR102425339B1 (ko) | 2014-12-08 | 2022-07-25 | 에프. 호프만-라 로슈 아게 | 비타민 d 의 측정을 위한 방법 |
| CN117491623A (zh) | 2015-08-20 | 2024-02-02 | 豪夫迈·罗氏有限公司 | 使用聚乙二醇化分析物特异性结合剂的基于颗粒的免疫测定法 |
| KR102437995B1 (ko) | 2016-03-07 | 2022-08-29 | 에프. 호프만-라 로슈 아게 | 항-p53 항체의 검출 |
| CN108698047B (zh) | 2016-03-11 | 2022-04-01 | 豪夫迈·罗氏有限公司 | 电化学发光检测中的支链胺 |
| EP3577460B1 (en) | 2017-02-02 | 2021-01-20 | Roche Diagnostics GmbH | Immunoassay using at least two pegylated analyte-specific binding agents |
| WO2019164180A1 (ko) * | 2018-02-21 | 2019-08-29 | 고려대학교 세종산학협력단 | 유기전계발광소자용 조성물, 이로부터 제조된 정공주입층 재료 및 정공주입층을 포함하는 유기전계발광소자 |
| US11686013B2 (en) | 2018-02-23 | 2023-06-27 | Meso Scale Technologies, Llc. | Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule |
| CN111936522B (zh) | 2018-04-18 | 2024-07-02 | 豪夫迈·罗氏有限公司 | 新型抗胸苷激酶抗体 |
| EP3844503B1 (en) | 2018-08-31 | 2024-05-29 | F. Hoffmann-La Roche AG | Thymidine kinase (tk-1) in prognostic indices for dlbcl |
| AU2019418498A1 (en) | 2019-01-03 | 2021-07-15 | Meso Scale Technologies, Llc | Compositions and methods for carrying out assay measurements |
| CN120098057A (zh) | 2019-03-01 | 2025-06-06 | 中尺度技术有限责任公司 | 用于免疫方法的被电化学发光标记的探针、使用这类探针的方法和包含这类探针的试剂盒 |
| CN120665985A (zh) | 2019-06-07 | 2025-09-19 | 豪夫迈·罗氏有限公司 | 杂交全lna寡核苷酸 |
| EP3999238B1 (en) | 2019-07-16 | 2025-11-26 | Meso Scale Technologies, LLC | Assay apparatuses, methods and reagents |
| CN114144674A (zh) | 2019-07-22 | 2022-03-04 | 豪夫迈·罗氏有限公司 | P物质作为用于子宫内膜异位症的非侵入性诊断的血液生物标志物 |
| KR20220016210A (ko) | 2019-07-22 | 2022-02-08 | 에프. 호프만-라 로슈 아게 | 자궁내막증의 비-침습적 진단용 혈액 생물표지자로써 s100a9 |
| JP7421631B2 (ja) | 2019-07-22 | 2024-01-24 | エフ． ホフマン－ラ ロシュ アーゲー | 子宮内膜症の非侵襲的診断のための血液バイオマーカーとしてのｓ１００ａ８ |
| KR20220024699A (ko) | 2019-07-22 | 2022-03-03 | 에프. 호프만-라 로슈 아게 | 자궁내막증의 비침습적 진단을 위한 혈액 바이오마커로서의 s100a12 |
| WO2021013786A1 (en) | 2019-07-22 | 2021-01-28 | F. Hoffmann-La Roche Ag | S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis |
| EP4058459A1 (en) | 2019-11-15 | 2022-09-21 | F. Hoffmann-La Roche AG | Derivatization of beta-lactam antibiotics for massspec measurements in patient samples |
| EP4154008A1 (en) | 2020-05-19 | 2023-03-29 | Meso Scale Technologies, LLC | Methods, compositions, and kits for nucleic acid detection |
| WO2022006236A1 (en) | 2020-07-01 | 2022-01-06 | Meso Scale Technologies, Llc. | Compositions and methods for assay measurements |
| AU2021327754A1 (en) | 2020-08-21 | 2023-03-30 | Meso Scale Technologies, Llc. | Electrochemical cells with auxiliary electrodes having a defined interface potential and methods of using them |
| EP4237441A1 (en) | 2020-11-02 | 2023-09-06 | F. Hoffmann-La Roche AG | Sars-cov-2 nucleocapsid antibodies |
| JP2023554517A (ja) | 2020-12-22 | 2023-12-27 | エフ． ホフマン－ラ ロシュ アーゲー | 試料中の目的の分析物を検出するための方法 |
| WO2022207628A1 (en) | 2021-03-30 | 2022-10-06 | F. Hoffmann-La Roche Ag | Scf as blood biomarker for the non-invasive diagnosis of endometriosis |
| CN117099001A (zh) | 2021-04-01 | 2023-11-21 | 豪夫迈·罗氏有限公司 | Psp94作为血液生物标志物用于子宫内膜异位症的非侵入性诊断 |
| CN117337394A (zh) | 2021-05-17 | 2024-01-02 | 豪夫迈·罗氏有限公司 | sFRP4作为血液生物标志物用于子宫腺肌病的非侵入性诊断 |
| TW202340716A (zh) | 2021-08-13 | 2023-10-16 | 美商梅梭刻度技術公司 | 電化學電池裝置及製造方法 |
| WO2023072904A1 (en) | 2021-10-26 | 2023-05-04 | F. Hoffmann-La Roche Ag | Monoclonal antibodies specific for sars-cov-2 rbd |
| KR20240146115A (ko) | 2021-12-30 | 2024-10-07 | 메소 스케일 테크놀러지즈, 엘엘시 | 전기화학발광 검출 방법 |
| AU2023205230A1 (en) | 2022-01-04 | 2024-06-27 | Meso Scale Technologies, Llc. | Electrochemical cell devices and methods of manufacturing |
| WO2023131594A1 (en) | 2022-01-05 | 2023-07-13 | F. Hoffmann-La Roche Ag | Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm) |
| US20250237656A1 (en) | 2022-02-18 | 2025-07-24 | Roche Diagnostics Operations, Inc. | Method for detecting an analyte of interest in a sample |
| JP2025520600A (ja) | 2022-06-23 | 2025-07-03 | エフ． ホフマン－ラ ロシュ アーゲー | 子宮内膜症を診断するためおよび子宮内膜症の病期を分類するための方法 |
| WO2024017983A1 (en) | 2022-07-22 | 2024-01-25 | F. Hoffmann-La Roche Ag | Meteorin-like protein (metrnl) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome |
| JP2025524025A (ja) | 2022-07-22 | 2025-07-25 | エフ． ホフマン－ラ ロシュ アーゲー | 多嚢胞性卵巣症候群の診断のための（血液）バイオマーカーとしてのロイコトリエンａ４ヒドロラーゼ（ｌｔａ４ｈ） |
| WO2024017985A1 (en) | 2022-07-22 | 2024-01-25 | F. Hoffmann-La Roche Ag | Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome |
| IL322791A (en) | 2023-02-15 | 2025-10-01 | Meso Scale Technologies Llc | Electrochemical cell devices and methods for their manufacture |
| WO2025017135A1 (en) | 2023-07-20 | 2025-01-23 | F. Hoffmann-La Roche Ag | Screening methods for antibody compositions |
| WO2025026908A1 (en) | 2023-07-28 | 2025-02-06 | Roche Diagnostics Gmbh | Serum epha1 as biomarker for endometriosis |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3905871A (en) * | 1971-05-14 | 1975-09-16 | Syva Co | Lactam conjugates to enzymes |
| US4238195A (en) * | 1979-01-18 | 1980-12-09 | Miles Laboratories, Inc. | Fluorescer-labeled specific binding assays |
| US4372745A (en) * | 1979-12-19 | 1983-02-08 | Electro-Nucleonics, Inc. | Chemical luminescence amplification substrate system for immunochemistry involving microencapsulated fluorescer |
| EP0050965A1 (en) * | 1980-10-23 | 1982-05-05 | Takeda Chemical Industries, Ltd. | Beta-lactamase inhibitory composition |
| US4396579A (en) * | 1981-08-06 | 1983-08-02 | Miles Laboratories, Inc. | Luminescence detection device |
| US4713328A (en) * | 1981-09-30 | 1987-12-15 | Yolken Robert H | Microbial Enzyme assays |
| JPS60200167A (ja) * | 1984-03-24 | 1985-10-09 | Toyobo Co Ltd | 化学発光法による過酸化水素の定量法 |
| US5221605A (en) * | 1984-10-31 | 1993-06-22 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US5310687A (en) * | 1984-10-31 | 1994-05-10 | Igen, Inc. | Luminescent metal chelate labels and means for detection |
| US4764462A (en) * | 1985-08-23 | 1988-08-16 | Georgetown University | Detectably labeled cephalosporin assay for beta-lactamase |
| DE3784610T2 (de) * | 1986-09-22 | 1993-09-23 | Nippon Kayaku Kk | Verfahren zur bestimmung von 1,5-anhydroglucitol und ausruestung dafuer. |
| US5057302A (en) * | 1987-02-13 | 1991-10-15 | Abbott Laboratories | Bifunctional chelating agents |
| JPH0630628B2 (ja) * | 1987-12-16 | 1994-04-27 | キング醸造株式会社 | 生細胞数及び活力の測定方法 |
| US5321143A (en) * | 1988-05-26 | 1994-06-14 | Massachusetts Institute Of Technology | Ruthenium-catalyzed production of cyclic sulfates |
| US5238610A (en) * | 1988-10-06 | 1993-08-24 | The United States Of America As Represented By The Secretary Of The Navy | Method of detecting oxidizing agents in aqueous media through the use of chemiluminescent microemulsions |
| US5264346A (en) * | 1991-06-03 | 1993-11-23 | Chen Kirk C S | Colorimetric method for beta-lactamase assay and its applications |
| US5321243A (en) * | 1992-02-18 | 1994-06-14 | International Verifact Inc. | Card reader apparatus with read head mounting structure and card guide |
-
1995
- 1995-06-07 US US08/485,419 patent/US5643713A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 WO PCT/US1996/009805 patent/WO1996040978A1/en not_active Ceased
- 1996-06-07 ES ES96923255T patent/ES2258777T3/es not_active Expired - Lifetime
- 1996-06-07 CA CA002222926A patent/CA2222926C/en not_active Expired - Fee Related
- 1996-06-07 DE DE69635822T patent/DE69635822T2/de not_active Expired - Fee Related
- 1996-06-07 AT AT96923255T patent/ATE317913T1/de not_active IP Right Cessation
- 1996-06-07 EP EP96923255A patent/EP0836651B1/en not_active Expired - Lifetime
- 1996-06-07 JP JP50202097A patent/JP3997436B2/ja not_active Expired - Fee Related
-
1997
- 1997-06-23 US US08/880,209 patent/US6165708A/en not_active Expired - Fee Related
-
2006
- 2006-12-13 JP JP2006335216A patent/JP2007176939A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6381796A (en) | 1996-12-30 |
| DE69635822D1 (de) | 2006-04-20 |
| AU708865B2 (en) | 1999-08-12 |
| US5643713A (en) | 1997-07-01 |
| US6165708A (en) | 2000-12-26 |
| CA2222926A1 (en) | 1996-12-19 |
| JPH11507533A (ja) | 1999-07-06 |
| EP0836651B1 (en) | 2006-02-15 |
| CA2222926C (en) | 2008-09-16 |
| ATE317913T1 (de) | 2006-03-15 |
| WO1996040978A1 (en) | 1996-12-19 |
| JP2007176939A (ja) | 2007-07-12 |
| EP0836651A1 (en) | 1998-04-22 |
| DE69635822T2 (de) | 2006-10-19 |
| EP0836651A4 (en) | 2004-07-14 |
| ES2258777T3 (es) | 2006-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3997436B2 (ja) | 電気化学発光技術による化合物のモニターリング | |
| JP3784072B2 (ja) | 電気化学発光酵素イムノアッセイ | |
| EP0837949B1 (en) | Electrochemiluminescent enzyme biosensors | |
| US5804400A (en) | Electrochemiluminescent assay | |
| IE904317A1 (en) | Use of a sparingly soluble salt of a heteropoly acid for the determination of an analyte, a corresponding method of determination as well as a suitable agent therefor | |
| US20050181443A1 (en) | Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same | |
| US6316180B1 (en) | Electrochemiluminescent monitoring of compounds/electrochemiluminescence assays | |
| ES2249065T3 (es) | Medicion de hidruro mediante el uso de compuestos quimioluminiscentes de acridinio. | |
| JP2005118014A (ja) | 分析方法およびそれに用いる試薬 | |
| GB1571466A (en) | Assay mehtod | |
| JP4702341B2 (ja) | フェニルアラニンセンサ及びフェニルアラニン測定方法 | |
| AU708865C (en) | Electrochemiluminescent monitoring of compounds | |
| JPH04507194A (ja) | 化学発光組成物、化学発光法、及び分析的検定におけるその使用 | |
| JP3867081B2 (ja) | 酸化還元指示薬としてのアミン−ｎ−オキサイドによるアナライトの蛍光測定 | |
| Alpuche-Aviles | Electrochemical Sensors with Inorganic Redox Mediators | |
| Martin | Chemiluminescence detection of NADH and enzyme substrates with immobilized tris (2, 2'-bipyridyl) ruthenium (II) and dehydrogenase enzymes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041018 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041102 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050201 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050318 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060815 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061213 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070125 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070601 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070613 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070703 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070725 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20070705 Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20070705 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100817 Year of fee payment: 3 |
|
| LAPS | Cancellation because of no payment of annual fees |